ARCHIVES

Schmidt’s Term On Cancer Panel Expires, No Word On Reappointment

This article is from The Cancer Letter archive.

Vol. 01 No. 09 | February 28, 1975

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC.

November 19, 2004

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980

Four CIDAC Contracts Will Go To Cancer Research Centers; RFPs To Be Released January or February

December 20, 1974

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984